News

Emerging Technology Insider Releases New TechTalks Video Interview with Pressure BioSciences’ CEO Richard T. Schumacher

SOUTH EASTON, MA / ACCESSWIRE / May 24, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company") today announced…

2 years ago

Predictmedix to Present at 12th Annual LD Micro Invitational

Interim CEO Dr. Rahul Kushwah to Present at 11:00 a.m. Pacific on June 7, 2022TORONTO, ON / ACCESSWIRE / May…

2 years ago

Jaguar Health Announces Presentation of an Investigator-initiated Evaluation of Crofelemer for a Severe Congenital Diarrheal Disorder at 2022 Digestive Disease Week

Microvillus inclusion disease (MVID) is a life-threatening and rare autosomal recessive disease that affects newborns and children resulting in significant…

2 years ago

Castellum, Inc. Announces Appointment of Former Congressman Jim Moran to Advisory Board

Castellum, Inc. Announces Appointment of Former Congressman Jim Moran to Advisory Board Castellum, Inc. (OTC: ONOV) announces that former Virginia…

2 years ago

Ogilvy Health Builds Upon Leadership Team With Courtney Murphy Joining the Agency as Global People Director

Courtney Murphy Global People DirectorNEW YORK, May 24, 2022 (GLOBE NEWSWIRE) -- Ogilvy Health today announced industry veteran, Courtney Murphy,…

2 years ago

Progyny Lands Employer Benefits Expert in Expansion of Leadership Team

Arielle Bogorad joins Progyny as Senior Vice President of Employer Market StrategyNEW YORK, May 24, 2022 (GLOBE NEWSWIRE) -- Progyny,…

2 years ago

Signati™ Medical, Inc. Debuts Innovative Bipolar Radio Frequency Sealing Platform at American Urological Association (AUA) Annual Meeting

Providence, RI, May 24, 2022 (GLOBE NEWSWIRE) -- Signati™ Medical, Inc. is pleased to announce the unveiling of their innovative…

2 years ago

AXIM Biotechnologies Completes Optimization of Only FDA-Cleared IgE Rapid Diagnostics Test – In-House Manufacturing Lowers Cost and Eliminates Supply Chain Expenditures

SAN DIEGO, May 24, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international…

2 years ago

SciSparc and Clearmind Medicine Inc. Collaboration Yields Positive Results for its Psychedelic Combination Treatment

Pre-clinical trials based on the proprietary combination demonstrate significant suppressive effect on alcohol consumption TEL AVIV, Israel, May 24, 2022…

2 years ago

P3 Health Partners Announces Receipt of Nasdaq Notice Regarding Late Filing of Periodic Reports

HENDERSON, Nev., May 24, 2022 (GLOBE NEWSWIRE) -- P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered…

2 years ago